OMERS Administration Corp’s Corcept Therapeutics CORT Stock Holding History

OMERS Administration Corp’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Buy	30,700 +3,500	+13%	+$211K	0.02%	493
2026 Q1	$1.1M	Buy	+27,200	New	+$1.02M	0.01%	633
2025 Q4	–	Sell	-8,700	Closed	-$723K	–	1112
2025 Q3	$723K	Buy	+8,700	New	+$630K	0.01%	649
2025 Q1	–	Sell	-44,500	Closed	-$2.24M	–	1051
2024 Q4	$2.24M	Sell	44,500 -52,900	-54%	-$2.77M	0.02%	301
2024 Q3	$4.51M	Sell	97,400 -20,900	-18%	-$743K	0.04%	174
2024 Q2	$3.84M	Buy	118,300 +64,100	+118%	+$1.76M	0.04%	192
2024 Q1	$1.37M	Hold	54,200	–	–	0.02%	143
2023 Q4	$1.76M	Buy	+54,200	New	+$1.49M	0.02%	117
2023 Q2	–	Sell	-339,000	Closed	-$7.34M	–	243
2023 Q1	$7.34M	Buy	+339,000	New	+$7.43M	0.11%	71

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's CORT Position: Q2 2026 in Review

OMERS Administration Corp increased its Corcept Therapeutics (CORT) stake by 13% in Q2 2026, buying an estimated $211K and bringing the position to 30,700 shares worth $2.67M. The position accounts for 0.02% of the portfolio, ranked #493.

OMERS Administration Corp first reported a position in CORT in Q1 2023 and has held it in 9 quarters since. The position peaked at $7.34M in Q1 2023. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

OMERS Administration Corp held 30,700 shares of Corcept Therapeutics worth $2.67M as of Q2 2026.
OMERS Administration Corp bought 3,500 Corcept Therapeutics shares in Q2 2026, an estimated $211K.
Corcept Therapeutics made up 0.02% of OMERS Administration Corp's portfolio in Q2 2026, its #493 holding.
OMERS Administration Corp first reported a position in Corcept Therapeutics in Q1 2023 and has held it in 9 quarters since.
OMERS Administration Corp's Corcept Therapeutics position peaked at $7.34M in Q1 2023.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.